Km. Taylor et al., FUNDAMENTAL DILEMMAS OF THE RANDOMIZED CLINICAL-TRIAL PROCESS - RESULTS OF A SURVEY OF THE 1,737 EASTERN-COOPERATIVE-ONCOLOGY-GROUP INVESTIGATORS, Journal of clinical oncology, 12(9), 1994, pp. 1796-1805
Purpose: We studied oncologists' attitudes and behavior with regard to
their participation in randomized clinical trials. Methods: We survey
ed the 1,737 physician members of the Eastern Cooperative Oncology Gro
up (ECOG) using the Physician Orientation Profile (POP), a self-admini
stered mailed questionnaire. A response rate of 86% was achieved (1,48
5 of 1,737); each physician's actual patient accrual was recorded. Res
ults: All respondents indicated that they had a systematic pattern of
patient preselection for entry onto trials beyond the formal inclusion
/exclusion trial criteria. Eighty-nine percent stated that improving p
atient qualify of life rather than prolonging survival was more person
ally satisfying. Sixty-two percent did not enter a single patient duri
ng the 12-month period following the survey, while 10% entered 80% of
all patients during that time. Physicians overestimated their accrual
rate by a factor of 6. Eighty-three percent defined randomization and
adherence to trial protocol as a serious challenge to their ability to
make individualized treatment decisions. Conclusion: This study raise
s questions regarding the following: (1) the perceived generalizabilit
y of trial findings, (2) the role of end points other than survival fo
r clinical trials, (3) the consequences of physician overestimation of
patient accrual, and (4) the impact of randomized trials on the behav
ior of clinicians. Further investigation into these critical issues wi
ll provide meaningful recommendations to enhance the future design, im
plementation, and conduct of randomized clinical trials in cancer. (C)
1994 by American Society of Clinicol Oncology.